Trademark: EVAMPLIX (BALSTILIMAB) 2253300
Word
EVAMPLIX (BALSTILIMAB)
Device Descrption:
3 CUBES,STACKED
ID
2253300
Trademark Type
Figurative
Status
Cancelled: Cancelled at the request of IB
Application Date
19 January 2022
Cancellation Date
07 November 2023
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases.
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases.